Kipos

Colecalciferol, the active ingredient in Kipos, is a Vitamin D presented as an oral dosage form for oral use. It treats vitamin D deficiency and supports bone health in adults and children.

GNH USA supplies Kipos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kipos is a vitamin D supplement that addresses disorders of calcium and phosphate metabolism. - Vitamin D deficiency: restores normal serum 25‑hydroxyvitamin D levels and improves bone mineralization. - Osteomalacia: alleviates bone softening, reducing bone pain and muscle weakness. - Rickets: prevents abnormal bone growth in children, supporting normal skeletal development.

Adverse reactions may occur with excessive intake or individual sensitivity.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Constipation: reduced bowel movements. - Dry mouth: sensation of oral dryness. - Headache: transient cranial discomfort. - Fatigue: feeling of tiredness. - Hypercalciuria: elevated urinary calcium excretion.

Serious or Rare Side Effects: - Hypercalcemia: excessive serum calcium causing weakness, arrhythmia, or renal stones. - Renal impairment: reduced kidney function due to calcium deposition. - Allergic reaction: rash, itching, or swelling. - Severe hypercalciuria: may lead to nephrolithiasis. - Hypersensitivity anaphylaxis: rare but potentially life‑threatening. - Persistent vomiting: may indicate severe toxicity.

Before using Kipos, consider the following safety measures. - Assess baseline calcium: ensure serum calcium is within normal range to avoid hypercalcemia. - Monitor renal function: patients with kidney disease should be observed for calcium accumulation. - Review concomitant vitamin D intake: avoid excessive total vitamin D from multiple sources. - Caution in elderly: higher risk of hypercalcemia and falls. - Pregnancy and lactation: use only if prescribed after risk‑benefit evaluation. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Kipos may interact with other medicines that affect calcium balance.

Major Interactions (Avoid): - Thiazide diuretics: increase risk of hypercalcemia. - Calcium supplements: additive effect on serum calcium levels. - Vitamin A excess: potentiates hypercalcemia. - Digitalis glycosides: heightened toxicity with elevated calcium. - High‑dose vitamin D analogues: may cause severe hypercalcemia.

Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., phenobarbital, phenytoin): may accelerate vitamin D metabolism, reducing efficacy. - Corticosteroids: can impair vitamin D activation, requiring dose adjustment. - Orlistat: may decrease absorption of fat‑soluble vitamins, including vitamin D. - Cholestyramine: can bind vitamin D, lowering its bioavailability. - Bisphosphonates: concurrent use may affect calcium homeostasis.